SJOGREN SYNDROME
Clinical trials for SJOGREN SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGREN SYNDROME trials appear
Sign up with your email to follow new studies for SJOGREN SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control OngoingThis study tests a drug called ianalumab in about 500 adults with active Sjogren's syndrome, an autoimmune disease causing dry eyes and mouth. Participants receive either the drug or a placebo to see if it reduces disease activity and symptoms over 48 weeks. The goal is to find a…
Matched conditions: SJOGREN SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control OngoingThis study tests a drug called ianalumab in people with active Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. About 276 adults with a recent diagnosis will receive either the drug or a placebo. The goal is to see if ianalumab can reduce disease activity…
Matched conditions: SJOGREN SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Rare disease pregnancy study withdrawn before start
Knowledge-focused TerminatedThis study was designed to track pregnancies in women with rare autoimmune diseases like lupus, arthritis, and scleroderma. The goal was to learn about complications and improve care. However, the study was withdrawn before enrolling any participants, so no results are available.
Matched conditions: SJOGREN SYNDROME
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 11, 2026 20:53 UTC